Mankind Pharma, India's fourth-largest pharmaceutical company, has announced the launch of its new campaign for HealthOK 100% vegetarian multivitamin tablets, featuring popular actress Archana Puran Singh, a strict vegetarian herself. This campaign aims to raise awareness about HealthOK's 100% vegetarian multivitamin tablets that provide complete
Prega News, India's leading pregnancy detection kit brand from Mankind Pharma, has unveiled its latest Women's Day campaign that addresses the critical issue of societal attitudes towards working mothers. The thought-provoking campaign video titled #shecancarryboth showcases how society often struggles to accept and appreciate women
Mankind Pharma, a renowned global pharmaceutical company, has set up a comprehensive healthcare camp at the Mahakumbh 2025 in Prayagraj, Uttar Pradesh, India, offering essential medical services and support to thousands of pilgrims. The initiative, which commenced on 13th January and will continue through to
Mankind Pharma Limited (BSE: 543904 | NSE: MANKIND) and Innovent Biologics have announced a groundbreaking partnership to exclusively license and commercialize sintilimab, an advanced PD-1 immunotherapy, in the Indian market. This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient
Mankind Pharma Limited has completed the transaction to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV), for a purchase consideration of INR 13,768 Crores. This strategic move marks a significant leap for Mankind Pharma, positioning it as a market leader in the Indian
Mankind Pharma, a reputed global pharmaceutical firm, executed a Business Transfer Agreement (BTA) to transfer its Over-the-Counter (OTC) business undertaking to its wholly owned subsidiary, Mankind Consumer Products Private Limited (MCPPL), on a slump sale basis. In Q1 FY25, the OTC business reported revenues of
Mankind Pharma, a reputed global pharmaceutical firm, has launched a comprehensive nationwide campaign to raise awareness about organ donation. The initiative, aligning with the company's motto of "Spreading Kindness," aims to address the critical shortage of organ donors in India, where the donation rate stands
Expands high entry barrier portfolio; Leadership in Women’s Health (#1 in Gynae IPM[i]) High entry barrier portfolio with specialty R&D tech platforms across - Recombinants, Niche Biologics, Novel Delivery and Immunoglobulins Only innovator in the world to develop patented recombinant Anti-D Brands across Women’s Health
Mankind Pharma Limited (BSE: 543904 | NSE: MANKIND) and Takeda Pharmaceutical Company Limited signed a Non-Exclusive Patent License Agreement for commercialising 'Vonoprazan' in the Indian market. The agreement allows Mankind Pharma to launch the novel drug for treating Gastroesophageal Reflux Disease (GERD) under its trademark. Vonoprazan
Mankind Pharma, the No.1 Pharmaceutical company in the antihypertensive Segment in India, as per MAT April’ 24 volume sale (Source: IQVIA) has launched a nationwide campaign on the occasion of World Hypertension Day called 'Limit White India'. This initiative aims to raise awareness about the
